Sanofi SA
LSE:0O59
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
S
|
Sanofi SA
LSE:0O59
|
FR |
|
P
|
Prime Energy PE Ltd
TASE:PRIM
|
IL |
|
Endurance Gold Corp
XTSX:EDG
|
CA |
|
L
|
Luotea Oyj
OMXH:LUOTEA
|
FI |
|
S
|
Sino United Worldwide Consolidated Ltd
OTC:SUIC
|
US |
|
Paradigm Gold Corp
OTC:NKLXD
|
CA |
Wall Street
Price Targets
0O59 Price Targets Summary
Sanofi SA
According to Wall Street analysts, the average 1-year price target for
0O59
is 98.22 EUR
with a low forecast of 57.481 EUR and a high forecast of 124.757 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is 0O59's stock price target?
Price Target
98.22
EUR
According to Wall Street analysts, the average 1-year price target for
0O59
is 98.22 EUR
with a low forecast of 57.481 EUR and a high forecast of 124.757 EUR.
What is Sanofi SA's Revenue forecast?
Projected CAGR
5%
For the last 14 years the
compound annual growth rate for
Sanofi SA's revenue is
2%.
The projected
CAGR
for the next 3 years is
5%.
What is Sanofi SA's Operating Income forecast?
Projected CAGR
12%
For the last 14 years the
compound annual growth rate for
Sanofi SA's operating income is
2%.
The projected
CAGR
for the next 3 years is
12%.
What is Sanofi SA's Net Income forecast?
Projected CAGR
16%
For the last 14 years the
compound annual growth rate for
Sanofi SA's net income is
2%.
The projected
CAGR
for the next 3 years is
16%.
